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ABSTRACT  
Introduction: Euphorbia antiquorum is a fleshy shrub belonging to the family Euphorbiaceae. It is widely distributed in the hotter parts of  
India. It is used as a substitute for the Ayurvedic drug ‘Snuhee’ whose accepted botanical source is Euphorbia neriifolia Linn. The leaf, stem, latex 
and root of Snuhee are used in treatment of diseases and conditions like, diabetes, coryza, and oedema. Objective: The present study is aimed 
to investigate the renal protective effect of  E. antiquorum alcoholic extracts of the stem   on alloxan (150mg/kg) induced d iabetic Wistar rats. 
Methods: All animals were treated for 21 days and sacrificed on the last day. Unwanted placebo effect in case of the control group was blocked 
by executing appropriate vehicle treatment and same animal handling pattern. Extract and standard drug doses given orally were suspended in 
0.9% normal saline. Blood samples were drawn from retro orbital sinus using Diethyl-ether anesthesia at weekly intervals for 3 weeks. Blood 
samples were labeled in such a way that analysis team was kept blind about groups and nature of the study design. Body weight  measurement 
and blood sampling were done on 1st, 7th, 14th and 21st day of the study. Conclusion: 21 days daily treatment with a test drug of ethanolic 
extract of stems of Euphorbia antiquorum significantly reduced the elevated Blood glucose level, Urinary Albumin, urine creatinine, serum 
creatinine in alloxan induced diabetic rats. 
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1. INTRODUCTION 
India as a country is blessed with a rich heritage of 
traditional medical systems along with rich biodiversity to 
accomplish the herbal needs, as therapeutic benefits 
administered by these traditional and alternative medical 
systems. The Indian systems of medicine are Ayurveda, 
Siddha and Unani, which use herbs and minerals in the 
formulations. India which use 15 agro-climatic zones, 4700 
plant species of which 15000 are reported to have medicinal 
properties varying degrees.[1] 
The various parts of  Euphorbia antiquorum have been 
associated with a number of pharmacological activities 
which are Cytotoxic activity, Hepatoprotective and 
antioxidant activity, Insecticidal activity of Euphorbia 
antiquorum L., Anti-hyperglycaemic and Insilco Aldose 
reductase inhibitory activity (Amutha, et al., 2012) , Cancer , 
Anti-inflammatory and anti-arthritic activities.[2-7] 
Diabetic nephropathy appears in patients with both type 1 
and type 2 diabetes after five to 10 years of active diabetes, 
and is heralded by the onset of abnormal amounts of 
albumin in the urine, termed micro-albuminuria, defined as a 
urinary albumin excretion rate of 20–200μg/min in a timed 
specimen, 30–300mg/24 hours, or an albumin to creatinine 
ratio of 30–300g albumin/mg creatinine on a morning spot 
urine test. The spot urine/creatinine ratio has been shown to 
have high sensitivity and specificity for urinary albumin 
excretion compared with a timed measurement of urinary 
albumin.[8] Diabetes is the most common cause of kidney 
failure, accounting for nearly 44 percent of new cases. Even 
when diabetes is controlled, the disease can lead to chronic 
kidney disease (CKD) and kidney failure. Kidney failure is the 
final stage of chronic kidney disease. Nearly 24 million 
people in the United States have diabetes and nearly 180 000 
people are living with kidney failure as a result of diabetes. 
The prevalence of nephropathy in India was less (8.9% in 
Vellore, 5.5% in Chennai) when compared with the 
prevalence of 22.3% in Asian Indians in the UK. In chronic 
renal failure patients the prevalence of diabetic nephropathy 
was 30.3% followed by chronic interstitial nephritis (23%) 
and chronic glomerulonephritis (17.7%).[9] 
Alloxan is most widely used in experimental diabetic 
research. Alloxan produces selective necrosis of the beta cells 
of pancreas. The alloxan is administered by various routes 
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like intravenous, intraperitoneal and subcutaneous. Alloxan 
is used for induction of diabetes in experimental animals 
such as mice, rats, rabbits and dogs. The routes and dose of 
alloxan required may vary depending upon the animal 
species.[10-11] 
2. MATERIALS AND METHODS 
 2.1. Plant material  
Fresh stems of E. antiquorum were collected from the 
vicinity of Varansi district in Uttar Pradesh, India during the 
month of January, 2018 and air dried. The plant material was 
identified and authenticated by Prof. N. K. Dubey, 
Taxonomist, FNASc and FNAAS, Center of Advanced Study in 
Botany, Institute of Science, BHU, Varanasi, India. The 
voucher herbarium specimen (Euphorbia.2018/4) has been 
deposited in the Department of Botany.  
2.2. Animals  
All the animals used for the study were healthy and active in 
their cage. Studies were carried out using male Wistar rats 
weighing 170-200 g. The animals were bred, reared and 
housed in the animal house of BNU University with CPCSEA 
no. (03/BNCP/IAEC/2018) . The rats were group housed in 
polyacrylic cages (38×23×10cm) with not more than six 
animals per cage and maintained under standard laboratory 
conditions (temperature 25 ± 2 0C) and relative humidity 
50% (±10%), with a dark and light cycle of 12 ± 1 h. They 
were allowed free access to standard dry pellet diet (Amrut, 
India) and water ad libitum and kept in quarantine for a 
week to acclimatize with animal house facility(CPCSEA 
guideline,7th January, 2010). The animals were maintained 
in accordance with the guidelines specified by the Committee 
for the Purpose of Control and Supervision of Experiments 
on Animals (CPCSEA), Ministry of Environment and Forests 
(Animal Welfare Division), Govt of India, New Delhi.  
2.3. Preparation of extracts  
Coarsely powdered (200 g) stem was extracted with 95% 
(V/ V) alcohol in a soxhlet apparatus. The extract obtained 
was filtered and subjected to concentration at a temperature 
below 50oC to obtain a dark brown semi solid mass [yield 
17.3% (W/W)]. The extract was suspended in distilled water 
and used for further studies [12-13] 
2.4. Experimental design . 
Group-I (Normal or vehicle control):  Group I animals were 
non diabetic and served as   normal control and received 
0.9% normal saline. Six healthy animals with moderate 
hyperglycemia, i.e. serum glucose between the normal 
ranges were randomly selected.  
Group II (Diabetic control): Rats served as diabetic control, 
which were injected a single dose of 150mg/kg b.w. of 
Alloxan monohydrate ( ip) with 0.9% normal saline.  
Group III: Diabetic rats were treated with ethanolic plant 
extract by gavages (200   mg/kg/day b.w., p.o) in 0.9% 
normal saline once daily for 21 days. 
Group IV: Diabetic rats were treated with ethanolic plant 
extract by gavages (400 mg/kg  b.w., p.o.) in 0.9% normal 
saline once daily for 21 days. 
Group V: Which served as positive control, diabetic rats 
were treated with metformin by gavages (200 mg/kg b.w., 
p.o.) in 0.9% normal saline once daily for 21 days.[14-15] 
All animals were treated for 21 days and sacrificed on the 
last day. Unwanted placebo   effect in case of each control 
group was blocked by executing appropriate vehicle 
treatment and same animal handling pattern. Extract and 
standard drug doses given orally were suspended in 0.9% 
normal saline. Blood samples were drawn from retro orbital 
sinus using diethyl-ether anesthesia after 3 weeks. Blood 
samples were labeled in such a way that analysis team was 
kept blind about groups and nature of study design. Body 
weight measurement and blood sampling were done on 21st 
day of the study. Animals (rats) were sacrificed, dissected 
and organs were cleaned and collected and kept in a suitable 
container.[16]
  
 
3. RESULTS 
Table 3.1: Effect of Euphorbia antiquorum ethanolic extract on blood glucose level in alloxan induced diabetic rat. 
Group 
 
Treatment Dose 
(mg/kg 
b. w.) 
Blood Glucose Level mg/dL (Mean±SEM) 
1st day 7th day 14th day 21st day 
1 NC - 115.5±3.030 111.1±9.42 110.6±8.25 105.5±3.03 
2 DC 150 122.6±25.31 260.42±32.44 281.22±36.27 303.3±23.12 
3 DC+EAE 200 119.12±4.88* 202.44±7.49** 229.47±8.28** 244.54±11.76*** 
4 DC+EAE 400 118.70±4.52* 172.0±4.517*** 198.0±4.517*** 188.0±4.517*** 
5 DC+Metformin 200 110.74±6.74* 131.5±8.44*** 134.5±6.41*** 128.8±4.55*** 
Statistical significance test was done by ANOVA followed by Tukey’s t test (n=6) 
Values are Mean ± SEM of 6 animals per group, *Difference in blood glucose level of a group when compared with diabetic 
control significant at p<0.01. **Difference in blood glucose level of a group when compared with diabetic control significant at 
p<0.05. ***Difference in blood glucose level of a group when compared with diabetic control significant at p<0.001.  
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Figure 3.2: Effect of Euphorbia antiquorum ethanolic extract on blood glucose level in alloxan induced diabetic rat. 
 
Table3.3:  Effect of Euphorbia antiquorum ethanolic extract on creatinine urine in alloxan induced diabetic rat. 
Group 
 
 
Treatment Dose 
(mg/kg 
b. w.) 
Creatinine Urine in mg/dL (Mean ± SEM) 
1st day 7th day 14th day 21st day 
1 NC - 76.49±3.71 79.22±4.23 78.55±4.55 74.88±5.14 
2 DC 150 78.76±7.09 84.44±6.44 96.46±7.22 99.28±8.43 
3 DC+EAE 200 78.47±2.45* 84.01±4.88* 93.45±5.74* 95.77±4.58* 
4 DC+EAE 400 77.54±4.22* 81.32±5.53* 90.87±6.52** 93.55±4.54** 
5 DC+Metformin 200 78.51±3.9* 80.34±3.46* 86.28±4.26*** 84.46±6.23*** 
Statistical significance test was done by ANOVA followed by Tukey’s t test (n=6) 
Values are Mean ± SEM of 6 animals per group, *Difference in Creatinine Urine level of a group when compared with diabetic 
control significant at p<0.01. **Difference in Creatinine Urine level of a group when compared with diabetic control significant 
at p<0.05. ***Difference in Creatinine Urine level of a group when compared with diabetic control significant at p<0.001.  
 
 
Figure 3.4: Effect of Euphorbia antiquorum ethanolic extract on creatinine urine in alloxan induced diabetic rat. 
Normal Control (NC)
Diabetic Control
(DC)-Dose 150mg/kg
b.w
DC+EAE-Dose
200mg/kg b.w
DC+EAE-Dose
400mg/kg b.w
DC+Metformin-Dose
200mg/kg b.w
1st day 115.5 122.6 119.12 118.7 110.74
7th day 111.1 260.42 202.44 172 131.5
14th day 110.6 281.22 229.47 198 134.5
21st day 105.5 303.3 244.54 188 128.8
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Table 3.5: Effect of Euphorbia antiquorum ethanolic extract on Serum creatinine urine  in alloxan induced diabetic rat. 
Group 
 
Treatment Dose 
(mg/kg 
b. w.) 
Serum Creatinine Urine in mg/dL (Mean ± SEM) 
1st day 7th day 14th day 21st day 
1 NC - 0.45±0.18 0.42±0.11 0.41±0.12 0.39±0.06 
2 DC 150 0.44±0.17 0.79±0.34 0.84±0.42 1.48±0.67 
3 DC+EAE 200 0.46±0.11* 0.78±0.16* 0.83±0.16* 1.11±0.28** 
4 DC+EAE 400 0.48±0.12* 0.72±0.24** 0.76±0.26** 0.80±0.25** 
5 DC+Metformin 200 0.46±0.06* 0.54±0.13*** 0.67±0.16*** 0.60±0.12*** 
Statistical significance test was done by ANOVA followed by Tukey’s t test (n=6) 
Values are Mean ± SEM of 6 animals per group, *Difference in serum creatinine urine level of a group when compared with 
diabetic control significant at p<0.01. **Difference in serum creatinine urine level of a group when compared with diabetic 
control significant at p<0.05. ***Difference in serum creatinine urine level of a group when compared with diabetic control 
significant at p<0.001.  
 
 
Figure 3.6:  Effect of Euphorbia antiquorum ethanolic extract on Serum creatinine in alloxan induced diabetic rat. 
 
Table 3.7: Effect of Euphorbia antiquorum ethanolic extract on Urinary Albumin in alloxan induced diabetic rat. 
Group 
 
Treatment Dose 
(mg/kg 
b.w.) 
Urinary Albumin in mg/day (Mean ± SEM) 
1st day 7th day 14th day 21st day 
1 NC - 1.50±0.07 1.52±0.15 1.54±0.12 1.54±0.22 
2 DC 150 1.55±0.19 14.55±3.12 23.55±3.21 31.46±6.29 
3 DC+EAE 200 1.54±0.24* 13.21±1.13* 19.28±1.44** 20.68±1.56** 
4 DC+EAE 400 1.52±0.34* 11.88±1.12** 17.22±1.34** 17.68±1.29*** 
5 DC+Metformin 200 1.52±0.46* 10.43±1.28*** 14.24±1.33*** 11.43±1.24*** 
Statistical significance test was done by ANOVA followed by Tukey’s t test (n=6) 
Values are Mean ± SEM of 6 animals per group, *Difference in urinary albumin level of a group when compared with diabetic 
control significant at p<0.01. **Difference in urinary albumin level of a group when compared with diabetic control significant 
at p<0.05. ***Difference in urinary albumin level of a group when compared with diabetic control significant at p<0.001.  
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Figure 3.8: Effect of Euphorbia antiquorum ethanolic extract on Urinary Albumin in alloxan induced diabetic rat. 
 
4. DISCUSSION 
4.1. Effect of different doses of ethanolic extract of stems 
of Euphorbia antiquorum (EAE) and metformin on blood 
glucose level of alloxan-induced diabetic rat: 
After administration of 7th day of EAE at doses of 400 mg/kg 
b.w. (Group IV) significantly (p<0.05) reduced the blood 
glucose of alloxan-induced diabetic rats (Table 3.1 & Figure 
3.2), somewhat similar to what was seen in the standard 
(metformin) group (Group V) at a significant level p<0.001. 
The animals of non-diabetic normal or vehicle control group 
(Group I) had fasting blood glucose levels of 115.5±3.030 
mg/dl at day 1st day and it was almost similar (105.5±3.03 
mg/dl) on 21st day, whereas that of diabetic control group 
was 122.6±25.31 mg/dl on 1st day and gradually increased 
and reach up to 303.3 ± 23.12 mg/dl (Group II) on 21st day. 
The treated group with EAE at doses of 200 mg/kg b.w. 
(Group III) showed significant (p<0.05) reduction of blood 
glucose levels of 119.12±4.88 mg/dL on 1st day to 
244.54±11.76 mg/dl (**p < 0.05 vs. diabetic control group) 
at day of 21. At the day 21 the doses of EAE at doses of 400 
mg/kg b.w. (Group IV) significantly reduced blood glucose 
levels to 188.0±4.517mg/dl (**p < 0.05 vs. diabetic control 
group). 
4.2. Effect of different doses of ethanolic extract of stems 
of Euphorbia antiquorum (EAE) and metformin on urine 
creatinine level of alloxan-induced diabetic rat: 
EAE at doses of 200 & 400 mg/kg b.w. (Group IV) 
significantly reduced the urine creatinine level of alloxan-
induced diabetic rats (Table 3.3 & Figure 3.4), similar to 
what was seen in the standard (metformin) group (Group V). 
The animals of non-diabetic normal or vehicle control group 
(Group I) had urine creatinine level of 74.88±5.14mg/dl at 
day 21, whereas that of diabetic control group was 
99.28±8.43mg/dl (Group II). The group treated with EAE at 
doses of 200 mg/kg b.w. (Group III) showed significant 
reduction of urine creatinine level of 95.77±4.58mg/dl (*p < 
0.01 vs. diabetic control group) at day of 21. At the day 21 
the doses of EAE at doses of 400 mg/kg b.w. (Group IV) 
significantly reduced urine creatinine level to 
93.55±4.54mg/dl (*p < 0.01 vs. diabetic control group). The 
urine creatinine level of EAE at doses of 400 mg/kg b.w. 
(Group IV) demonstrated a notable significant decline to 
93.55±4.54mg/dl (*p < 0.01 vs. diabetic control group) but 
which is not even better than metformin (200 mg/Kg b.w) 
treated group (Group V) that reduced urine creatinine level 
to 84.46±6.23mg/dl (*p < 0.001 vs. diabetic control group) at 
day of 21. 
4.3. Effect of different doses of ethanolic extract of stems 
of Euphorbia antiquorum (EAE) and metformin on serum 
creatinine level of alloxan-induced diabetic rat: 
EAE at doses of 200 & 400 mg/kg b.w. (Group IV) 
significantly reduced the serum creatinine level of alloxan-
induced diabetic rats (Table 3.5 & Figure 3.6), similar to 
what was seen in the standard (metformin) group (Group V). 
The animals of non-diabetic normal or vehicle control group 
(Group I) had serum creatinine level of 0.39±0.06mg/dl at 
day 21, whereas that of diabetic control group was 
1.48±0.67mg/dl (Group II). The group treated with EAE at 
doses of 200 mg/kg b.w. (Group III) showed significant 
reduction of serum creatinine level of 1.11±0.28mg/dl (*p < 
0.01 vs. diabetic control group) at day of 21. At the day 21 
the doses of EAE at doses of 400 mg/kg b.w. (Group IV) 
significantly reduced serum creatinine level to 
0.80±0.25mg/dl (*p < 0.05 vs. diabetic control group). The 
serum creatinine level of EAE at doses of 400 mg/kg b.w. 
(Group IV) demonstrated a notable significant decline to 
0.80±0.25mg/dl (*p < 0.05 vs. diabetic control group) but 
which is not even better than metformin (200 mg/Kg b.w) 
treated group (Group V) that reduced serum creatinine level 
to 0.60±0.12mg/dl (***p < 0.001 vs. diabetic control group) 
at day of 21. 
4.4. Effect of different doses of ethanolic extract of stems 
of Euphorbia antiquorum (EAE) and metformin on 
urinary albumin level of alloxan-induced diabetic rat: 
EAE at doses of 200 & 400 mg/kg b.w. (Group IV) 
significantly reduced the urinary albumin level of alloxan-
induced diabetic rats (Table 3.7 & Figure 3.8), similar to 
what was seen in the standard (metformin) group (Group V). 
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1st day 1.5 1.55 1.54 1.52 1.52
7th day 1.52 14.55 13.21 11.88 10.43
14th day 1.54 23.55 19.28 17.22 14.24
21st day 1.54 31.46 20.68 17.68 11.43
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The animals of non-diabetic normal or vehicle control group 
(Group I) had urinary albumin level of 1.54±0.22mg/dl at 
day 21, whereas that of diabetic control group was 
3.14±0.69mg/dl (Group II). The group treated with EAE at 
doses of 200 mg/kg b.w. (Group III) showed significant 
reduction of urinary albumin level of 2.99±0.83mg/dl (***p < 
0.01 vs. diabetic control group) at day of 21. At the day 21 
the doses of EAE at doses of 400 mg/kg b.w. (Group IV) 
significantly reduced urinary albumin level to 
1.87±0.79mg/dl (***p < 0.001 vs. diabetic control group). 
The urinary albumin level of EAE at doses of 400 mg/kg b.w. 
(Group IV) demonstrated a notable significant decline to 
1.87±0.79mg/dl (***p < 0.001 vs. diabetic control group) but 
which is not even better than metformin (200 mg/Kg b.w) 
treated group (Group V) that reduced urinary albumin level 
to 1.62±0.24mg/dl (***p < 0.001 vs. diabetic control group) 
at day of 21. 
5. CONCLUSION 
According to the standard working protocol, 21 days daily 
treatment with a test drug of ethanolic extract of stems of 
Euphorbia antiquorum significantly reduced the elevated 
Urinary Albumin, urine creatinine, serum creatinine in 
alloxan induced diabetic rats. Euphorbia antiquorum with 
oral hypoglycemic agents may be a valuable adjutant therapy 
to achieve and/or maintain glycemic control and possibly 
reduce or delay the onset of diabetic complications. Thus, 
these results offer scientific validation of ethanolic extract of 
stems of Euphorbia antiquorum in the management of 
diabetes mellitus in time-honored medicine system of India. 
Further studies will be carried out in future to identify the 
active antidiabetic principles of this plant that are 
responsible. It can be thereby suggested further for the 
investigations on humans to study the harmonizing effect of 
the amalgamation of ethanolic extract of stems of  Euphorbia 
antiquorum and metformin on other body tissues. 
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